Makana Therapeutics
PrivateLast Round
Grant
Jun 12, 2023
Total Funding Raised
$2.25M
Company Overview
Makana Therapeutics is a biotechnology company that develops genetically modified pigs for xenotransplantation to address the organ donor shortage.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Makana Therapeutics Comparables
Compare Makana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| eGenesis | 84% | |
| NZeno | 84% | |
| PorMedTec Co., Ltd. | 81% |
Makana Therapeutics Funding Rounds
Historical fundraising activity
Makana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kidney Innovation Accelerator | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 33% MoM.
- Jan 20, 2026
Monthly visitors increased 67% MoM, reaching 2.2K.
Makana Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Makana Therapeutics's valuation, stock price, and market status.
Is Makana Therapeutics a public or private company?
Makana Therapeutics is a private company.
What is the current stock price of Makana Therapeutics?
Makana Therapeutics is a private company, so its shares have no public market price. Caplight tracks Makana Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Makana Therapeutics worth (valuation)?
Valuation information for Makana Therapeutics is not publicly available.
Can I buy Makana Therapeutics stock?
Makana Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Makana Therapeutics's last funding round?
Makana Therapeutics's most recent funding round was Grant on June 12, 2023.
Who are the main investors in Makana Therapeutics?
Key investors in Makana Therapeutics include Kidney Innovation Accelerator.
Will Makana Therapeutics IPO soon?
No public IPO plans have been announced for Makana Therapeutics.
How can I track Makana Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Makana Therapeutics's shares on secondary markets.